l-dopa modulates motor cortex excitability in Alzheimer’s disease patients
- 2 July 2008
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 115 (9) , 1313-1319
Abstract
In Alzheimer’s disease (AD), transcranial magnetic stimulation (TMS) studies have shown abnormalities of motor cortical excitability, such as a decreased intra-cortical inhibition (ICI) and changes in resting motor threshold (rMT). We studied the effects of l-dopa on rMT and ICI in a cohort of moderate AD patients after paired-pulse TMS. Results were compared with a control group of healthy subjects. As expected, AD patients showed a significant reduction in ICI and a lower rMT. l-dopa administration (soluble form, melevodopa 200 mg) promptly reversed the ICI impairment up to normalization. This effect was specific, since it was not mimicked in control subjects. These results indicate a possible role of dopamine in modulating AD cortical excitability, thus suggesting an interaction between dopaminergic ascending pathways and endogenous intracortical transmitters. In addition, considering that l-dopa showed a pharmacological profile similar to the one of cholinomimetics, l-dopa might represent a reliable tool to study new therapeutic perspective and strategies for AD.Keywords
This publication has 52 references indexed in Scilit:
- Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's diseaseNeurobiology of Aging, 2007
- Clinical Efficacy of a Single Afternoon Dose of Effervescent Levodopa-Carbidopa Preparation (CHF 1512) in Fluctuating Parkinson DiseaseClinical Neuropharmacology, 2007
- Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapsesNeuropharmacology, 2007
- TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortexJournal of Neural Transmission, 2006
- Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: A potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine releaseJournal of Comparative Neurology, 2005
- Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine ReleaseMolecular Pharmacology, 2004
- Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: Evidence of impaired glutamatergic neurotransmission?Annals of Neurology, 2003
- D1 receptors in prefrontal cells and circuitsBrain Research Reviews, 2000
- Optimal Focal Transcranial Magnetic Activation of the Human Motor CortexJournal Of Clinical Neurophysiology, 1992
- Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkeyJournal of Comparative Neurology, 1983